Results 161 to 170 of about 12,533 (219)
Low maternal pertussis protection and quantified infant risk: supporting maternal Tdap vaccination in China. [PDF]
Front ImmunolWang W, Zhang T, Sun X.
europepmc +1 more source
Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.
JAMA Netw OpenMorabito G +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Clinics of North America, 2000
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M D, Decker, K M, Edwards
openaire +4 more sources
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M D, Decker, K M, Edwards
openaire +4 more sources
Acellular Pertussis Vaccine Booster
Pediatrics, 1993The editors of Pediatrics have asked us to comment on the study by Pichichero et al,1 because our report of booster vaccination with this vaccine, published in Pediatrics in 1989,2 raised some questions with regard to the safety of the vaccine. The present study, with a design similar to ours, showed different and far more encouraging results: no ...
M, Blennow, M, Granstrom
openaire +2 more sources
Pertussis vaccine controversies and acellular pertussis vaccine
The Indian Journal of Pediatrics, 2003Pertussis still continues to cause significant morbidity and mortality worldwide. Because of the high reactogenicity of whole cell pertussis vaccine, it had evoked public controversy in several countries. In 1970 Japan abandoned use of whole cell pertussis vaccine and mounted efforts to develop better vaccine.
Raju C, Shah, Anuj R, Shah
openaire +2 more sources
ACELLULAR PERTUSSIS VACCINES IN ADULTS
Infectious Disease Clinics of North America, 1999The pathogenesis of pertussis, and the epidemiology and clinical manifestations of pertussis after childhood are reviewed as a background for a discussion of recent clinical trials of acellular pertussis vaccines in adults, and the vaccines' potential for routine use in adolescents and adults.
W A, Keitel, K M, Edwards
openaire +2 more sources
Acellular pertussis vaccines in China
Vaccine, 2012In China, whole-cell pertussis (Pw) vaccines were produced in the early 1960s and acellular pertussis (Pa) vaccines were introduced in 1995. Pa vaccines have now almost completely replaced Pw vaccines in the national immunization program. To strengthen the regulation of vaccines used in China, a vaccine lot release system was established in 2001 and Pa
Lichan, Wang +2 more
openaire +2 more sources
Acellular Pertussis Vaccines for Adolescents
The Pediatric Infectious Disease Journal, 2005The epidemiology of pertussis is changing, with a clear increase in the number of cases diagnosed in adolescents and adults. This development has spurred studies and anticipated licensure of safer diphtheria, tetanus, acellular pertussis combined (Tdap) vaccines for this older population.Literature review.Tdap vaccines are safe and immunogenic when ...
Michael E, Pichichero, Janet R, Casey
openaire +2 more sources